Coeptis Therapeutics

Articles by Coeptis Therapeutics

Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared

Crypto January 7, 2026

WEXFORD, Pa., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (Coeptis or the Company), a next-gen technology and biopharmaceutical company, , announced today thaοΏ½...